Symptom Burden Prevalent in Childhood Cancer Survivors
By Elana Gotkine HealthDay Reporter
THURSDAY, May 9, 2024 -- Symptom burden is prevalent among young childhood cancer survivors, with caregiver anxiety and greater neighborhood deprivation associated with greater symptom burden, according to a study published online May 7 in JAMA Network Open.
Madeline R. Horan, Ph.D., from the St. Jude Children's Research Hospital in Memphis, Tennessee, and colleagues examined the prevalence of symptom burden among young childhood cancer survivors in a cross-sectional analysis. The study included 302 dyads of children aged 8 to 18 years who survived at least five years beyond diagnosis and their primary caregivers.
The researchers found that 62.0, 25.7, and 12.3 percent of the survivors had low, moderate, and high global cumulative symptom burden, respectively. There was an association for greater caregiver anxiety with moderate global symptom burden (risk ratio, 1.56). Moderate global symptom burden was seen in association with greater neighborhood deprivation (risk ratio, 4.86). Survivors with greater meaning/purpose were less likely to have moderate and high global symptom burden. Similar patterns were displayed for the burden of individual symptoms. Associations with lower health-related quality of life (HRQOL) were seen for low and moderate/high general pain (Cohen d, −0.60 and −0.98), moderate/high numbness (d, −0.99), and moderate/high worry (d, −0.55).
"Interventions targeting specific symptoms, family dynamics, and positive psychology to promote resilience, and offering resources to cope with challenging physical environments in their neighborhoods could alleviate symptom burden and enhance HRQOL for young, long-term cancer survivors," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted May 2024
Read this next
ASCO: Germline Variation Does Not Predict Taxane-Induced Peripheral Neuropathy
FRIDAY, June 7, 2024 -- Germline variation does not predict the risk of taxane-induced peripheral neuropathy (TIPN) in Black women receiving paclitaxel (once weekly) or docetaxel...
Smoking Cessation Aids Equally Effective in Those With Mental Health Conditions
THURSDAY, June 6, 2024 -- Popular smoking cessation aids are equally effective in those with or without a history of mental health conditions, according to a study published...
Study Looks at Links Between Cognition, Psychopathology, Weight in Preteens
WEDNESDAY, June 5, 2024 -- Lower cognition and greater psychopathology at baseline are associated with increased weight gain for children entering adolescence, according to a...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.